1460879976-fc5336a2-cda3-43cb-81e1-7c6c8682e2ea

1. A composition comprising nucleic acid nanotubes having a uniform length, wherein each nanotube comprises a plurality of linked double-stranded nucleiacid helices, and wherein each nanotube is formed from at least one single-stranded scaffold nucleic acid molecule and a plurality of staple oligonucleotides.
2. The composition of claim 1, wherein the nucleic acid is DNA.
3. The composition of claim 1, wherein the average length of the nucleic acid nanotubes is given by the length of the single-stranded scaffold nucleic acid divided by the number of double stranded nucleic acid helices comprising each nanotube.
4. The composition of claim 1, wherein the distance between crossovers between any two adjacent helices is at least 10 base pairs.
5. The composition of claim 1, wherein there are at least two crossovers between any pair of adjacent helices.
6. The composition of claim 1, wherein each staple oligonucleotide comprises at least 7 base pairs, and links at least two non-contiguous segments of the single-stranded scaffold nucleic acid.
7. The composition of claim 6, wherein each staple oligonucleotide comprises 32 base pairs.
8. The composition of claim 6, wherein each staple oligonucleotide comprises 54 base pairs.
9. The composition of claim 1, wherein each staple oligonucleotide comprises 42 base pairs, and links three non-contiguous segments of the single-stranded scaffold nucleic acid.
10. The composition of claim 1, wherein the average length of the nucleic acid nanotubes is greater than 50 nanometers.
11. The composition of claim 1, wherein the average length of the nucleic acid nanotubes is about 400 nanometers.
12. The composition of claim 1, wherein each nucleic acid nanotube comprises at least three double-stranded nucleic acid helices.
13. The composition of claim 1, wherein each nucleic acid nanotube comprises at least four double-stranded nucleic acid helices.
14. The composition of claim 1, wherein each nucleic acid nanotube comprises five double-stranded nucleic acid helices.
15. The composition of claim 1, wherein each nucleic acid nanotube comprises six double-stranded nucleic acid helices.
16. The composition of claim 1, wherein each nucleic acid nanotube comprises seven double-stranded nucleic acid helices.
17. The composition of claim 1, wherein the standard deviation of the lengths of the nucleic acid nanotubes is no more than 20% of the average nanotube length.
18. The composition of claim 1, wherein the standard deviation of the lengths of the nucleic acid nanotubes is no more than 10% of the average nanotube length.
19. The composition of claim 1, wherein the nucleic acid nanotubes form a liquid crystalline phase.
20. The composition of claim 19, wherein the nucleic acid nanotubes in liquid crystal phase are birefringent.
21. The composition of claim 19, wherein the nucleic acid nanotubes in liquid crystal phase give rise to measurable residual dipolar couplings in a solution with detergent-solubilized membrane protein.
22. The composition of claim 1, wherein the scaffold nucleic acid is derived from a natural source.
23. The composition of claim 1, wherein the scaffold nucleic acid is derived from M13 DNA.
24. The composition of claim 1, wherein the scaffold nucleic acid is artificial.
25. The composition of claim 1, further comprising a protein.
26. The composition of claim 25, further comprising a detergent.
27. The composition of claim 26, wherein the protein is a membrane protein.
28. The composition of claim 25, wherein the protein is present at a concentration of at least 0.1 mM.
29. A method of making nucleic acid nanotubes comprising the steps of:
(a) preparing a solution comprising a single-stranded scaffold nucleic acid and a plurality of staple oligonucleotides;
(b) heating the solution to denature the scaffold nucleic acid and staple oligonucleotides; and
(c) cooling the solution to assemble the nanotubes;
wherein the nucleic acid nanotubes have a uniform length.
30. The method of claim 29, wherein the solution is heated to about 90 degrees C.
31. The method of claim 29, wherein the solution is cooled by allowing it to stand at room temperature for at least 2 hours.
32. The method of claim 29, wherein the solution is cooled by allowing it to stand at room temperature for about 20 hours.
33. A method of performing NMR spectroscopy of proteins using nucleic acid nanotubes comprising the steps of:
(a) suspending nucleic acid nanotubes in a solution;
(b) forming a liquid crystalline phase comprising the nucleic acid nanotubes;
(c) adding a protein to the solution; and
(d) performing NMR spectroscopy on the protein and nucleic acid nanotube mixture.
34. The method of claim 33, wherein the protein is a membrane protein.
35. The method of claim 33, wherein the solution comprises a detergent.
36. The method of claim 33, wherein the protein is present at a concentration of at least 0.1 mM.
37. A plurality of nucleic acid nanotubes having a uniform length, wherein each nanotube comprises a plurality of linked double-stranded nucleic acid helices, and wherein each nanotube is formed from at least one single-stranded scaffold nucleic acid molecule and a plurality of staple oligonucleotides.
38. The composition of claim 1, wherein the nucleic acid nanotubes comprise at least two basepair sequences;
the first basepair sequence nanotube having a first head end and a first tail end, said first head end comprising paired complementary strands of nucleic acids, and said first tail end comprising a plurality of first unpaired strands of nucleic acids; and
the second basepair sequence nanotube having a second head end and a second tail end, said second head end comprising a plurality of second unpaired strands of nucleic acids, and said second tail end comprising paired complementary strands of nucleic acids; wherein
said first unpaired strands of nucleic acids are substantially complementary to said second unpaired strands of nucleic acids.
39. The composition of claim 1, wherein the average length of the nucleic acid nanotubes is about 800 nanometers.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. An optical element comprising:
a plurality of through holes in a transparent film matrix, wherein the plurality of through holes are placed in a state where axial directions thereof are approximately in parallel with one another, and the axial directions of the through holes are inclined or approximately parallel to a thickness direction of the transparent film matrix.
2. The optical element according to claim 1, wherein a diameter of the through hole is in a range from 0.5 to 10 \u03bcm.
3. The optical element according to claim 1, wherein a thickness is in a range from 10 to 470 \u03bcm.
4. A directional diffusion film comprising:
an optical element, wherein the optical element is the optical element according to claim 1.
5. A method of manufacturing an optical element comprising a plurality of through holes in a transparent film matrix, wherein the plurality of through holes are placed in a state where axial directions thereof are approximately in parallel with one another, the axial directions of the through holes are inclined or approximately parallel to a thickness direction of the transparent film matrix, and the through holes are filled with a low-molecular substance, and wherein
the method comprises processes of:
providing an optical element-forming material containing a monomer having a photopolymerizable functional group and the low-molecular substance, the difference between the SP values thereof being in a range from 1.5 to 3;
forming an optical element-forming material layer by coating a first substrate with the optical element-forming material; and
irradiating the optical element-forming material layer with a parallel beam.
6. The method of manufacturing an optical element according to claim 5, wherein the monomer has an SP value in a range from 11.7 to 13.4.
7. The method of manufacturing an optical element according to claim 5, wherein the low-molecular substance has an SP value in a range from 9.7 to 10.4.
8. The method of manufacturing an optical element according to claim 5, wherein the monomer is at least a liquid crystalline monomer.
9. The method of manufacturing an optical element according to claim 5, wherein the monomer has at least two polymerizable functional groups, and the polymerizable functional groups are acrylate groups.
10. The method of manufacturing an optical element according to claim 5, wherein the low-molecular substance is a solvent.
11. The method of manufacturing an optical element according to claim 5, wherein on the optical element-forming material layer on the first substrate in the process of forming the optical element-forming material layer, a second substrate is further placed, the optical element-forming material layer is interposed, between the both substrates, and the optical element-forming material layer is irradiated with the parallel beam in this state.
12. The method of manufacturing an optical element according to claim 5, further comprising a process of:
removing the low-molecular substance after the process of parallel beam irradiation.
13. The method of manufacturing an optical element according to claim 12, wherein after the process of removing the low-molecular substance, portions winch are obtained by removing low-molecular substance are filled with a substance having a refractive index different from that of a polymer made in the process of parallel beam irradiation by polymerization.
14. An optical element manufactured by the method of manufacturing an optical element according to claim 5.